Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 23;34(5):NP13–NP15. doi: 10.1177/11206721241256150

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — (A) Slit-lamp photograph before starting interferon alfa-2b treatment. External photograph depicting in right eye an inferior corneal infiltrate with stromal neovascularization branching from a conjunctival vessel. The lesion extended at limbus for 4 mm (white arrow) and 3.5 mm into cornea (white arrow). (B) Anterior segment optical coherence tomography (AS-OCT) findings. AS-OCT illustrated the abnormal hyper-reflective region (asterisk) suggestive of ocular surface squamous neoplasia. The lesion extended for about 50% of corneal depth. (C) Slit-lamp photograph after six months of interferon alfa-2b treatment. External photograph after 6 months of interferon alfa-2b treatment. The corneal infiltrate improved dramatically with regression of neovascularization and restored corneal transparency.